Photoacoustic Imaging in Detecting Ovarian or Fallopian Tube Cancer
| Status: | Withdrawn |
|---|---|
| Conditions: | Ovarian Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - 80 |
| Updated: | 11/30/2018 |
| Start Date: | September 2016 |
| End Date: | November 2018 |
Transvaginal Ultrasound and Photoacoustic Imaging of the Ovaries and the Fallopian Tubes: A Clinical Feasibility Study
This pilot clinical trial studies how well photoacoustic imaging works in detecting ovarian
or fallopian tube cancer. Photoacoustic imaging is an imaging method that uses lasers to
light up tissue, and then converts the light information into ultrasound images.
Photoacoustic imaging can provide images of the structure of tissues, as well as their
function and the levels of molecules, such as the flow of blood in blood vessels and the
level of oxygen in the blood. Photoacoustic imaging may help doctors determine whether a mass
is benign (non-cancerous) or cancerous based on the molecular differences between cancer and
normal tissue. It may be more accurate and less expensive than other imaging methods, and
does not expose patients to radiation.
or fallopian tube cancer. Photoacoustic imaging is an imaging method that uses lasers to
light up tissue, and then converts the light information into ultrasound images.
Photoacoustic imaging can provide images of the structure of tissues, as well as their
function and the levels of molecules, such as the flow of blood in blood vessels and the
level of oxygen in the blood. Photoacoustic imaging may help doctors determine whether a mass
is benign (non-cancerous) or cancerous based on the molecular differences between cancer and
normal tissue. It may be more accurate and less expensive than other imaging methods, and
does not expose patients to radiation.
PRIMARY OBJECTIVES:
I. To assess the performance of photoacoustic imaging (PAI) in detection of ovarian cancer in
a clinical setting and to help improve the design of the next generation hand held PAI probe.
SECONDARY OBJECTIVES:
I. To evaluate vasculature and oxygen saturation in lesions based on PAI-measurements.
OUTLINE:
Patients undergo PAI over 15-30 minutes prior to the ovarian excision.
I. To assess the performance of photoacoustic imaging (PAI) in detection of ovarian cancer in
a clinical setting and to help improve the design of the next generation hand held PAI probe.
SECONDARY OBJECTIVES:
I. To evaluate vasculature and oxygen saturation in lesions based on PAI-measurements.
OUTLINE:
Patients undergo PAI over 15-30 minutes prior to the ovarian excision.
Inclusion Criteria:
- Patients must be undergoing ovarian resection
- Ability to understand and the willingness to sign a written informed consent document
Exclusion Criteria:
- Patients who have had primary surgical excision
- Pregnant or lactating women
We found this trial at
1
site
Click here to add this to my saved trials
